• Citer

A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience

par Haubrich, Richard;Thompson, Melanie;Schooley, Robert;Lang, William;Stein, Allan;Sereni, Daniel;Van Der Ende, Marchina;Antunes, Francisco;Richman, Douglas D;Pagano, Grace;Kahl, Lesley;Fetter, Anny;Brown, David J.David;Clumeck, Nathan
Référence AIDS, 13, 17, page (2411-2420)
Publication Publié, 1999

Article révisé par les pairs

• Détails

Titre:	A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience
Auteur:	Haubrich, Richard; Thompson, Melanie; Schooley, Robert; Lang, William; Stein, Allan; Sereni, Daniel; Van Der Ende, Marchina; Antunes, Francisco; Richman, Douglas D; Pagano, Grace; Kahl, Lesley; Fetter, Anny; Brown, David J.David; Clumeck, Nathan
Informations sur la publication:	AIDS, 13, 17, page (2411-2420)
Statut de publication:	Publié, 1999
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Amprenavir
	Antiretroviral therapy
	Lamivudine
	Protease inhibitor
	Zidovudine
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0269-9370
	info:doi/10.1097/00002030-199912030-00013
	info:scp/0032777353